CN Patent

CN108602834B — 一种布鲁顿酪氨酸激酶抑制剂

Assigned to Beijing Shengnuoji Pharmaceutical Technology Co Ltd · Expires 2021-01-08 · 5y expired

What this patent protects

本发明涉及一种布鲁顿酪氨酸激酶抑制剂，该抑制剂具有如下式(Ⅰ)所示结构，该抑制剂对具有良好的选择性抑制效果，

USPTO Abstract

本发明涉及一种布鲁顿酪氨酸激酶抑制剂，该抑制剂具有如下式(Ⅰ)所示结构，该抑制剂对具有良好的选择性抑制效果，

Drugs covered by this patent

Patent Metadata

Patent number
CN108602834B
Jurisdiction
CN
Classification
—
Expires
2021-01-08
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Shengnuoji Pharmaceutical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.